Endoscopic radiofrequency ablation for malignant biliary obstruction
作者机构:Department of Gastroenterology and HepatologyInstitute for Clinical and Experimental MedicinePraha 14021Czech Republic Department of Internal Medicine II–Gastroenterology and GeriatricsUniversity Hospital OlomoucFaculty of Medicine and DentristryPalacky University OlomoucOlomouc 77900Czech Republic
出 版 物:《World Journal of Gastrointestinal Oncology》 (世界胃肠肿瘤学杂志(英文版)(电子版))
年 卷 期:2021年第13卷第10期
页 面:1383-1396页
核心收录:
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
基 金:The Czech Grant Research Council No.17-30281A
主 题:Radiofrequency Ablation Biliary Stenosis Cholangiocarcinoma Pancreatic cancer
摘 要:Cholangiocarcinoma and pancreatic cancer are the most common causes of malignant biliary *** majority of patients are diagnosed at a late stage when surgical resection is rarely *** these cases,palliative chemotherapy and radiotherapy provide only limited benefit and are associated with poor *** ablation(RFA)is a procedure for locoregional control of tumours,whereby a high-frequency alternating current turned into thermal energy causes coagulative necrosis of the tissue surrounding the *** subsequent release of debris and tumour antigens by necrotic cells can stimulate local and systemic *** development of endoluminal RFA catheters has led to the emergence of endoscopically delivered RFA,a treatment mainly used for malignant biliary strictures to prolong survival and/or stent *** indications include recanalisation of occluded biliary stents and treatment of intraductal ampullary adenoma or benign biliary *** article presents a comprehensive review of endobiliary RFA,mainly focusing on its use in patients with malignant biliary *** available data suggest that biliary RFA may be a promising modality,having positive impacts on survival and stent patency and boasting a reasonable safety ***,further studies with better characterised and stratified patient populations are needed before the method becomes accepted within routine clinical practice.